Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events
BackgroundAlthough studies have shown that glycemic variability is positively associated with an increased risk of cardiovascular disease, few studies have compared hemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) variability with adverse cardiovascular events in patients with type 2 diabetes...
Main Authors: | Lijuan Sheng, Guifang Yang, Xiangping Chai, Yang Zhou, Xin Sun, Zhenhua Xing |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2024.1323571/full |
Similar Items
-
Fasting plasma glucose variability and HbA1c are associated with peripheral artery disease risk in type 2 diabetes
by: Chun-Pai Yang, et al.
Published: (2020-01-01) -
Association of long-term visit-to-visit variability of HbA1c and fasting glycemia with hypoglycemia in type 2 diabetes mellitus
by: Chen Long, et al.
Published: (2022-08-01) -
Glycemic dispersion: a new index for screening high glycemic variability
by: Rui Shi, et al.
Published: (2023-05-01) -
Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions
by: Jingyang Chen, et al.
Published: (2023-06-01) -
Changes in body mass index and waist circumference and heart failure in type 2 diabetes mellitus
by: Yang Zhou, et al.
Published: (2023-12-01)